Search Within CLSI
C29-T
Title:
Standardization of Sodium and Potassium Ion Selective Electrode Systems to the Flame Photometric Reference Method; Tentative Standard
Organization: CLSI
Year: 1992
Status: Inactive
H30-T
Title:
Procedure for the Determination of Fibrinogen in Plasma; Tentative Guideline
Organization: CLSI
Year: 1991
Status: Inactive
M2
Title:
Performance Standards for Antimicrobial Disk Susceptibility Tests
Organization: CLSI
Year: 2003
Status: Inactive
GP06-A
Title:
Inventory Control Systems for Laboratory Supplies; Approved Guideline
Organization: CLSI
Year: 1994
Status: Inactive
GP10-A
Title:
Assessment of the Clinical Accuracy of Laboratory Tests Using Receiver Operating Characteristic (ROC) Plots; Approved Guideline
Organization: CLSI
Year: 1995
Status: Inactive
EP7-P
Title:
Interference Testing in Clinical Chemistry, Proposed Guideline
Organization: CLSI
Year: 1986
Status: Inactive
EP13-R
Title:
Laboratory Statistics - Standard Deviation; A Report
Organization: CLSI
Year: 1995
Status: Inactive
AUTO01-A
Title:
Laboratory Automation: Specimen Container/Specimen Carrier; Approved Standard
Organization: CLSI
Year: 2000
Status: Active
GP15-A3
Title:
Cervicovaginal Cytology Based on the Papanicolaou Technique; Approved Guideline
Organization: CLSI
Year: 2008
Status: Inactive
DI02-A2
Title:
Immunoprecipitin Analyses: Procedures for Evaluating the Performance of Materials; Approved Guideline
Organization: CLSI
Year: 1993
Status: Inactive
M21-A
Title:
Methodology for the Serum Bactericidal Test; Approved Guideline
Organization: CLSI
Year: 1999
Status: Inactive
LA1-A2
Title:
Assessing the Quality of Radioimmunoassay Systems; Approved Guideline
Organization: CLSI
Year: 1994
Status: Inactive
GP20-A2
Title:
Fine-Needle Aspiration Biopsy (FNAB) Techniques; Approved Guideline
Organization: CLSI
Year: 2003
Status: Inactive
I/LA06-A
Title:
Detection and Quantitation of Rubella IgG Antibody: Evaluation and Performance Criteria for Multiple Component Test Products, Specimen Handling, and Use of Test Products in the Clinical Laboratory;...
Organization: CLSI
Year: 1997
Status: Inactive
I/LA02-A2
Title:
Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens: (1) Indirect Fluorescence Assay for Microscopy and (2) Microtiter Enzyme Immunoassay Methods; Approved Guideline
Organization: CLSI
Year: 2006
Status: Inactive
DI03-A
Title:
Agglutination Analyses: Antibody Characteristics, Methodology, Limitations, and Clinical Validation; Approved Guideline
Organization: CLSI
Year: 1993
Status: Inactive
MM02-A2
Title:
Immunoglobin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline
Organization: CLSI
Year: 2002
Status: Inactive
I/LA19-A
Title:
Primary Reference Preparations Used to Standardize Calibration of Immunochemical Assays for Serum Prostate Specific Antigen (PSA); Approved Guideline
Organization: CLSI
Year: 1997
Status: Inactive
I06-A
Title:
Service of Clinical Laboratory Instruments; Approved Guideline
Organization: CLSI
Year: 1984
Status: Inactive
I02-A2
Title:
Temperature Calibration of Water Baths, Instruments, and Temperature Sensors-Second Edition; Approved Standard
Organization: CLSI
Year: 1990
Status: Inactive
MM04
Title:
Quality Assurance for Immunocytochemistry
Organization: CLSI
Status: Inactive
M100 TABLES 1A-1C QUICK GUIDE
Title:
M100 Tables 1A - 1C Quick Guide (M100 QG)
Organization: CLSI
Year: 2011
Status: Active
NRSCL 12-P
Title:
Sourcebook of Reference Methods, Materials, and Related Information for the Clinical Laboratory; Proposed Guideline
Organization: CLSI
Year: 1984
Status: Inactive
NRSCL 13-A
Title:
The Reference System for the Clinical Laboratory: Criteria for Development and Credentialing of Methods and Materials for Harmonization of Results; Approved Guideline
Organization: CLSI
Year: 2000
Status: Inactive
M11-S1
Title:
Performance Standards for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Informational Supplement
Organization: CLSI
Year: 2009
Status: Inactive
C39-A
Title:
A Designated Comparison Method for the Measurement of Ionized Calcium in Serum; Approved Standard
Organization: CLSI
Year: 2000
Status: Inactive
GP23-A2
Title:
Nongynecological Cytology Specimens: Preexamination, Examination, and Postexamination Processes; Approved Guideline
Organization: CLSI
Year: 2014
Status: Inactive
M45
Title:
Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria
Organization: CLSI
Year: 2016
Status: Active
M02-A13
Title:
Performance Standards for Antimicrobial Disk Susceptibility Tests
Organization: CLSI
Year: 2018
Status: Active
M07-A11
Title:
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
Organization: CLSI
Year: 2018
Status: Active
C64
Title:
Quantitative Measurement of Proteins and Peptides by Mass Spectrometry
Organization: CLSI
Year: 2021
Status: Active
M07,M100
Title:
M07 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; M100 Performance Standards for Antimicrobial Susceptibility Testing
Organization: CLSI
Year: 2021
Status: Active
EP43
Title:
Implementing a Laboratory Test Under Emergency Use Conditions
Organization: CLSI
Year: 2021
Status: Active
NBS09
Title:
Newborn Screening for X-Linked Adrenoleukodystrophy
Organization: CLSI
Year: 2021
Status: Active
M23S2
Title:
Process to Submit Disk Content (Potency) Data for Joint CLSI-EUCAST Working Group Review and Approval
Organization: CLSI
Year: 2021
Status: Active
MM24
Title:
Molecular Methods for Genotyping and Strain Typing of Infectious Organisms
Organization: CLSI
Year: 2021
Status: Active
H62
Title:
Validation of Assays Performed by Flow Cytometry
Organization: CLSI
Year: 2021
Status: Active
QMS04
Title:
Laboratory Design
Organization: CLSI
Year: 2016
Status: Active
QMS19
Title:
Customer Focus in a Quality Management System
Organization: CLSI
Year: 2017
Status: Active
QMS21
Title:
Purchasing and Inventory Management
Organization: CLSI
Year: 2016
Status: Active
QMS24
Title:
Using Proficiency Testing and Alternative Assessment to Improve Medical Laboratory Quality
Organization: CLSI
Year: 2016
Status: Active
EP39
Title:
A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests
Organization: CLSI
Year: 2021
Status: Active
C52
Title:
Toxicology and Drug Testing in the Medical Laboratory
Organization: CLSI
Year: 2017
Status: Active
M39
Title:
Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data
Organization: CLSI
Year: 2022
Status: Active
M57
Title:
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
Organization: CLSI
Year: 2016
Status: Active
GP48
Title:
Essential Elements of a Phlebotomy Training Program
Organization: CLSI
Year: 2017
Status: Active
M47
Title:
Principles and Procedures for Blood Cultures
Organization: CLSI
Year: 2022
Status: Active
EP26
Title:
User Evaluation of Acceptability of a Reagent Lot Change
Organization: CLSI
Year: 2022
Status: Active
QMS15
Title:
Laboratory Internal Audit Program
Organization: CLSI
Year: 2022
Status: Active
EP27
Title:
Constructing and Interpreting an Error Grid for Quantitative Measurement Procedures
Organization: CLSI
Year: 2022
Status: Active
C62
Title:
Liquid Chromatography-Mass Spectrometry Methods
Organization: CLSI
Year: 2022
Status: Active
NBS07
Title:
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid a-Glucosidase Activity Assays
Organization: CLSI
Year: 2017
Status: Active
NBS04
Title:
Newborn Screening by Tandem Mass Spectrometry
Organization: CLSI
Year: 2017
Status: Active
EP14-A4
Title:
Evaluation of Commutability of Processed Samples
Organization: CLSI
Year: 2022
Status: Active
M27M44S
Title:
Performance Standards for Antifungal Susceptibility Testing of Yeasts
Organization: CLSI
Year: 2022
Status: Active
M38M51S
Title:
Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi
Organization: CLSI
Year: 2022
Status: Active
M57S
Title:
Epidemiological Cutoff Values for Antifungal Susceptibility Testing
Organization: CLSI
Year: 2022
Status: Active
EP07
Title:
Interference Testing in Clinical Chemistry
Organization: CLSI
Year: 2018
Status: Active
EP15IG2
Title:
User Verification of Bias (Trueness) Implementation Guide
Organization: CLSI
Year: 2021
Status: Active
EP15IG1
Title:
User Verification of Precision Implementation Guide
Organization: CLSI
Year: 2021
Status: Active
EP17-IG
Title:
Evaluation of Detection Capability Implementation Guide
Organization: CLSI
Year: 2021
Status: Active
EP26IG
Title:
User Evaluation of Acceptability of a Reagent Lot Change Implementation Guide
Organization: CLSI
Year: 2022
Status: Active
EP34IG
Title:
Verification of an Extended Measuring Interval Implementation Guide
Organization: CLSI
Year: 2022
Status: Active
EP06IG
Title:
User Verification of Linearity Implementation Guide
Organization: CLSI
Year: 2022
Status: Active
EP21IG
Title:
Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures Implementation Guide
Organization: CLSI
Year: 2021
Status: Active
M24S
Title:
Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes
Organization: CLSI
Year: 2023
Status: Active
H47
Title:
One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test
Organization: CLSI
Year: 2023
Status: Active
EP12
Title:
Evaluation of Qualitative, Binary Output Examination Performance
Organization: CLSI
Year: 2023
Status: Active
M100
Title:
Performance Standards for Antimicrobial Susceptibility Testing
Organization: CLSI
Year: 2023
Status: Active
MM09
Title:
Human Genetic and Genomic Testing Using Traditional and High-Throughput Nucleic Acid Sequencing Methods
Organization: CLSI
Year: 2023
Status: Active
NBS02-ED3
Title:
Newborn Screening Follow-up and Education
Organization: CLSI
Year: 2023
Status: Active
EP25
Title:
Evaluation of Stability of In Vitro Medical Laboratory Test Reagents
Organization: CLSI
Year: 2023
Status: Active
AUTO17
Title:
Semantic Interoperability for In Vitro Diagnostic Systems
Organization: CLSI
Year: 2023
Status: Active
QMS18
Title:
Process Management
Organization: CLSI
Year: 2023
Status: Active
MM01
Title:
Molecular Testing for Heritable Genetics and Specimen Identification
Organization: CLSI
Year: 2023
Status: Active
EP33
Title:
Use of Delta Checks in the Medical Laboratory
Organization: CLSI
Year: 2023
Status: Active
PRE04
Title:
Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations
Organization: CLSI
Year: 2023
Status: Active
MM18
Title:
Interpretive Criteria for Identification of Bacteria and Fungi by Targeted DNA Sequencing
Organization: CLSI
Year: 2018
Status: Active
EP34
Title:
Establishing and Verifying an Extended Measuring Interval Through Specimen Dilution and Spiking
Organization: CLSI
Year: 2018
Status: Active
EP23
Title:
Laboratory Quality Control Based on Risk Management
Organization: CLSI
Year: 2023
Status: Active
C63
Title:
Laboratory Support for Pain Management Programs
Organization: CLSI
Year: 2018
Status: Active
C49
Title:
Analysis of Body Fluids in Clinical Chemistry
Organization: CLSI
Year: 2018
Status: Active
M53
Title:
Criteria for Laboratory Testing and Diagnosis of Human Immunodeficiency Virus Infection
Organization: CLSI
Year: 2023
Status: Active
QMS17
Title:
External Assessments, Audits, and Inspections of the Laboratory
Organization: CLSI
Year: 2023
Status: Active
POCT04
Title:
Essential Tools for Implementation and Management of a Point-of-Care Testing Program
Organization: CLSI
Year: 2016
Status: Active
POCT17
Title:
Use of Glucose Meters for Critically Ill Patients
Organization: CLSI
Year: 2016
Status: Active
VET01S
Title:
Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
Organization: CLSI
Year: 2024
Status: Active
VET01
Title:
Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
Organization: CLSI
Year: 2024
Status: Active